Corrigendum: Liquid chromatograph-mass spectrometry-based non-targeted metabolomics discovery of potential endogenous biomarkers associated with prostatitis rats to reveal the effects of magnoflorine.

Yuan, Yin; Dong, Fei-Xue; Liu, Xu; Xiao, Hong-Bin; Zhou, Zhong-Guang

Yuan, Yin; Dong, Fei-Xue; Liu, Xu; Xiao, Hong-Bin; Zhou, Zhong-Guang.

Afiliação

Yuan Y; Department of Basic Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
Dong FX; First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Liu X; Department of Basic Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
Xiao HB; Department of Basic Medicine, College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
Zhou ZG; Research Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.

Front Pharmacol ; 13: 1034753, 2022.

Article em En | MEDLINE | ID: mdl-36313346

Palavras-chave

UPLC-MS; metabolite biomarkers; metabolites; metabolomics; pathways

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google